High incidence of severe hand-foot syndrome during capecitabine-docetaxel combination chemotherapy.
Park
Y H
YH
Ryoo
B-Y
BY
Lee
H J
HJ
Kim
S A
SA
Chung
J-H
JH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000077143:Docetaxel; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005533:Foot Dermatoses / Q000139:chemically induced*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D015994:Incidence; D008297:Male; D012720:Severity of Illness Index; D013274:Stomach Neoplasms / Q000188:drug therapy; D013577:Syndrome; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects*
D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000069287:Capecitabine; D005472:Fluorouracil